Logo image of MHUA

MEIHUA INTERNATIONAL MEDICAL (MHUA) Stock Fundamental Analysis

NASDAQ:MHUA - Nasdaq - KYG5966G1082 - Common Stock - Currency: USD

0.2849  -0.01 (-3.68%)

Premarket: 0.28 0 (-1.72%)

Fundamental Rating

5

Overall MHUA gets a fundamental rating of 5 out of 10. We evaluated MHUA against 189 industry peers in the Health Care Equipment & Supplies industry. MHUA has an excellent financial health rating, but there are some minor concerns on its profitability. MHUA has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

MHUA had positive earnings in the past year.
MHUA had a positive operating cash flow in the past year.
Each year in the past 5 years MHUA has been profitable.
In multiple years MHUA reported negative operating cash flow during the last 5 years.
MHUA Yearly Net Income VS EBIT VS OCF VS FCFMHUA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 0 10M -10M 20M

1.2 Ratios

Looking at the Return On Assets, with a value of 9.12%, MHUA belongs to the top of the industry, outperforming 91.01% of the companies in the same industry.
Looking at the Return On Equity, with a value of 10.93%, MHUA belongs to the top of the industry, outperforming 85.71% of the companies in the same industry.
MHUA has a better Return On Invested Capital (8.53%) than 89.95% of its industry peers.
The Average Return On Invested Capital over the past 3 years for MHUA is in line with the industry average of 7.69%.
Industry RankSector Rank
ROA 9.12%
ROE 10.93%
ROIC 8.53%
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
MHUA Yearly ROA, ROE, ROICMHUA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 10 20 30

1.3 Margins

The Profit Margin of MHUA (11.47%) is better than 88.36% of its industry peers.
MHUA's Profit Margin has declined in the last couple of years.
MHUA's Operating Margin of 14.44% is amongst the best of the industry. MHUA outperforms 83.60% of its industry peers.
MHUA's Operating Margin has declined in the last couple of years.
The Gross Margin of MHUA (33.97%) is worse than 71.96% of its industry peers.
MHUA's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 14.44%
PM (TTM) 11.47%
GM 33.97%
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
MHUA Yearly Profit, Operating, Gross MarginsMHUA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 10 20 30 40

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MHUA is still creating some value.
The number of shares outstanding for MHUA remains at a similar level compared to 1 year ago.
The number of shares outstanding for MHUA has been increased compared to 5 years ago.
MHUA has a worse debt/assets ratio than last year.
MHUA Yearly Shares OutstandingMHUA Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 5M 10M 15M 20M
MHUA Yearly Total Debt VS Total AssetsMHUA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 50M 100M 150M

2.2 Solvency

An Altman-Z score of 3.01 indicates that MHUA is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 3.01, MHUA is in the better half of the industry, outperforming 70.37% of the companies in the same industry.
The Debt to FCF ratio of MHUA is 1.37, which is an excellent value as it means it would take MHUA, only 1.37 years of fcf income to pay off all of its debts.
MHUA's Debt to FCF ratio of 1.37 is amongst the best of the industry. MHUA outperforms 91.01% of its industry peers.
A Debt/Equity ratio of 0.08 indicates that MHUA is not too dependend on debt financing.
MHUA has a better Debt to Equity ratio (0.08) than 61.38% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.37
Altman-Z 3.01
ROIC/WACC1.3
WACC6.59%
MHUA Yearly LT Debt VS Equity VS FCFMHUA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 0 50M 100M

2.3 Liquidity

MHUA has a Current Ratio of 4.78. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA has a better Current ratio (4.78) than 73.55% of its industry peers.
MHUA has a Quick Ratio of 4.74. This indicates that MHUA is financially healthy and has no problem in meeting its short term obligations.
MHUA has a Quick ratio of 4.74. This is in the better half of the industry: MHUA outperforms 78.31% of its industry peers.
Industry RankSector Rank
Current Ratio 4.78
Quick Ratio 4.74
MHUA Yearly Current Assets VS Current LiabilitesMHUA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

1

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 13.80% over the past year.
The Earnings Per Share has been decreasing by -8.81% on average over the past years.
Looking at the last year, MHUA shows a decrease in Revenue. The Revenue has decreased by -6.00% in the last year.
The Revenue has been growing slightly by 5.11% on average over the past years.
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.93%
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MHUA Yearly Revenue VS EstimatesMHUA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M

5

4. Valuation

4.1 Price/Earnings Ratio

MHUA is valuated cheaply with a Price/Earnings ratio of 0.45.
Based on the Price/Earnings ratio, MHUA is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
MHUA is valuated cheaply when we compare the Price/Earnings ratio to 28.87, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 0.45
Fwd PE N/A
MHUA Price Earnings VS Forward Price EarningsMHUA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of MHUA indicates a rather cheap valuation: MHUA is cheaper than 100.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 1.06
EV/EBITDA -0.45
MHUA Per share dataMHUA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4

4.3 Compensation for Growth

The decent profitability rating of MHUA may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MHUA!.
Industry RankSector Rank
Dividend Yield N/A

MEIHUA INTERNATIONAL MEDICAL

NASDAQ:MHUA (4/28/2025, 8:24:59 PM)

Premarket: 0.28 0 (-1.72%)

0.2849

-0.01 (-3.68%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-29 2022-11-29/bmo
Earnings (Next)N/A N/A
Inst Owners0.8%
Inst Owner Change0%
Ins Owners49.95%
Ins Owner ChangeN/A
Market Cap9.09M
AnalystsN/A
Price TargetN/A
Short Float %0.08%
Short Ratio0.11
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.45
Fwd PE N/A
P/S 0.06
P/FCF 1.06
P/OCF 1.04
P/B 0.06
P/tB 0.06
EV/EBITDA -0.45
EPS(TTM)0.64
EY224.64%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.27
FCFY94.57%
OCF(TTM)0.27
OCFY95.86%
SpS4.47
BVpS4.69
TBVpS4.67
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 9.12%
ROE 10.93%
ROCE 13.75%
ROIC 8.53%
ROICexc 9.64%
ROICexgc 9.67%
OM 14.44%
PM (TTM) 11.47%
GM 33.97%
FCFM 6.03%
ROA(3y)8.61%
ROA(5y)12.96%
ROE(3y)10.61%
ROE(5y)16.01%
ROIC(3y)8.98%
ROIC(5y)13.13%
ROICexc(3y)10.01%
ROICexc(5y)15.52%
ROICexgc(3y)10.12%
ROICexgc(5y)15.69%
ROCE(3y)14.05%
ROCE(5y)20.48%
ROICexcg growth 3Y-27.88%
ROICexcg growth 5Y-29.21%
ROICexc growth 3Y-28.39%
ROICexc growth 5Y-29.35%
OM growth 3Y-16.94%
OM growth 5Y-9.84%
PM growth 3Y-17.5%
PM growth 5Y-10.18%
GM growth 3Y-6.44%
GM growth 5Y-4.15%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF 1.37
Debt/EBITDA 0.56
Cap/Depr 24.8%
Cap/Sales 0.08%
Interest Coverage 86.2
Cash Conversion 41.41%
Profit Quality 52.59%
Current Ratio 4.78
Quick Ratio 4.74
Altman-Z 3.01
F-Score4
WACC6.59%
ROIC/WACC1.3
Cap/Depr(3y)537.79%
Cap/Depr(5y)817.43%
Cap/Sales(3y)2.75%
Cap/Sales(5y)4.76%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)13.8%
EPS 3Y-20.04%
EPS 5Y-8.81%
EPS Q2Q%-47.93%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-6%
Revenue growth 3Y2.91%
Revenue growth 5Y5.11%
Sales Q2Q%-5.91%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y3.36%
EBIT growth 3Y-14.53%
EBIT growth 5Y-5.23%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y79.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y124.85%
OCF growth 3Y-24.7%
OCF growth 5Y-28.07%